Suzanne Robotti
@surobotti.bsky.social
MedShadow Foundation founder and chief advocate. DES Action USA executive director. Patient safety advocate. Balancing the risks and benefits of medicines
Our new site is open! It is faster, prettier, better organized, and it has a host of options for getting informed and involved.
And best of all we still remain independent of pharmaceutical support.
With over a million site visitors a year, please check us out
MedShadow.org
And best of all we still remain independent of pharmaceutical support.
With over a million site visitors a year, please check us out
MedShadow.org
MedShadow Foundation | Shedding Light on the Risks & Benefits of Medications
MedShadow.org
December 18, 2025 at 6:26 PM
Our new site is open! It is faster, prettier, better organized, and it has a host of options for getting informed and involved.
And best of all we still remain independent of pharmaceutical support.
With over a million site visitors a year, please check us out
MedShadow.org
And best of all we still remain independent of pharmaceutical support.
With over a million site visitors a year, please check us out
MedShadow.org
After years of running a nonprofit news site that reports on drugs and side effects, I wanted a doctor who could help me prioritize safer, less invasive options. So, I added Integrative Care.
I Didn’t Quit Western Medicine. I Added Integrative Care - MedShadow Foundation
After years of running a news site that reports on drug side effects, I wanted a doctor who could help me prioritize less invasive options
medshadow.org
December 16, 2025 at 9:28 PM
After years of running a nonprofit news site that reports on drugs and side effects, I wanted a doctor who could help me prioritize safer, less invasive options. So, I added Integrative Care.
We recently hosted the 3rd webinar in our series Investigating Generics: Are Any of Us Safe from Faulty Drugs?
See host Emma Yasinski who’s
at the forefront of this issue & two experts: Reshma Ramachandran, M.D. and Marta Wosińska, Ph.D.
Watch it here: medshadow.org/webinar/inve...
See host Emma Yasinski who’s
at the forefront of this issue & two experts: Reshma Ramachandran, M.D. and Marta Wosińska, Ph.D.
Watch it here: medshadow.org/webinar/inve...
Investigating Generic Drugs: Are Any of Us Safe from Faulty Generics?
Join this urgent public discussion with patients, doctors, pharmacists, researchers and journalists to examine and improve generic drug safety and efficacy.
medshadow.org
November 22, 2025 at 11:07 PM
We recently hosted the 3rd webinar in our series Investigating Generics: Are Any of Us Safe from Faulty Drugs?
See host Emma Yasinski who’s
at the forefront of this issue & two experts: Reshma Ramachandran, M.D. and Marta Wosińska, Ph.D.
Watch it here: medshadow.org/webinar/inve...
See host Emma Yasinski who’s
at the forefront of this issue & two experts: Reshma Ramachandran, M.D. and Marta Wosińska, Ph.D.
Watch it here: medshadow.org/webinar/inve...
There’s a problem with generic drug safety — is our gov finally noticing? MedShadow’s amazing senior writer, @Emma Yasinski, published this insightful recap of the recent Senate Committee on Aging hearing on MedShadow’s website. I highly recommend it: medshadow.org/senate-probe...
INVESTIGATING GENERICS: Senate Probes Drug Manufacturing Failures and Risks to U.S. Supply - MedShadow Foundation | Independent Health & Wellness Journalism
At a Sept. 17th hearing, experts testified that cost-cutting, overseas labs, and weak oversight are putting Americans at risk
medshadow.org
October 3, 2025 at 1:29 PM
There’s a problem with generic drug safety — is our gov finally noticing? MedShadow’s amazing senior writer, @Emma Yasinski, published this insightful recap of the recent Senate Committee on Aging hearing on MedShadow’s website. I highly recommend it: medshadow.org/senate-probe...
92% of medicines we take are generic drugs and the FDA assures us these drugs are bioequivalent to the brand name. Unfortunately that’s not always the case.
I explored that topic in a recent MedShadow webinar. I'll soon share info on upcoming webinars. See you there! www.youtube.com/watch?v=2f17...
I explored that topic in a recent MedShadow webinar. I'll soon share info on upcoming webinars. See you there! www.youtube.com/watch?v=2f17...
Are Your Generic Drugs Safe? Webinar Highlights & What’s Coming Next
YouTube video by MedShadow Foundation
www.youtube.com
August 25, 2025 at 6:44 PM
92% of medicines we take are generic drugs and the FDA assures us these drugs are bioequivalent to the brand name. Unfortunately that’s not always the case.
I explored that topic in a recent MedShadow webinar. I'll soon share info on upcoming webinars. See you there! www.youtube.com/watch?v=2f17...
I explored that topic in a recent MedShadow webinar. I'll soon share info on upcoming webinars. See you there! www.youtube.com/watch?v=2f17...
I recently spoke with Chris Burress for his Live Beyond the Norms podcast about my time on an FDA Advisory Comm. We discuss how the FDA works and my experience there, as well as ADHD and generic drugs. I hope you’ll check out this honest conversation. www.livebeyondthenorms.com/episode/the-...
The Hidden Dangers in Your Medicine Cabinet | FDA Advisor Suzanne Robotti on Flawed Trials, Drug Safety & Patient Advocacy – Live Beyond the Norms
www.livebeyondthenorms.com
July 22, 2025 at 3:40 PM
I recently spoke with Chris Burress for his Live Beyond the Norms podcast about my time on an FDA Advisory Comm. We discuss how the FDA works and my experience there, as well as ADHD and generic drugs. I hope you’ll check out this honest conversation. www.livebeyondthenorms.com/episode/the-...
Go Cindy Pearson, on @medshadow.bsky.social Board. She spoke up for patient safety and for including independent public input at the WHI #hormonereplacement FDA meeting
www.nytimes.com/2025/07/17/h...
www.nytimes.com/2025/07/17/h...
F.D.A. Panelists Call for Removal of Warnings on Menopause Treatments
www.nytimes.com
July 21, 2025 at 5:01 PM
Go Cindy Pearson, on @medshadow.bsky.social Board. She spoke up for patient safety and for including independent public input at the WHI #hormonereplacement FDA meeting
www.nytimes.com/2025/07/17/h...
www.nytimes.com/2025/07/17/h...
Investigating Generic Drug Safety doesn’t sound sexy, but it can save your life!
Listen to:
Joe Graedon of The People's Pharmacy
Katherine Eban, author, Bottle of Lies
David Y. Light founder, Valisure
Watch now for free! Investigating Generic Drug Safety medshadow.org/webinar/inve...
Listen to:
Joe Graedon of The People's Pharmacy
Katherine Eban, author, Bottle of Lies
David Y. Light founder, Valisure
Watch now for free! Investigating Generic Drug Safety medshadow.org/webinar/inve...
Investigating Generic Drugs: How Poor Quality Generic Drugs Cause Harm
Webinar Series: Investigating Generic Drugs Join this urgent public discussion with patients, doctors, pharmacists, researchers and journalists to examine and improve generic drug safety.
medshadow.org
June 27, 2025 at 11:37 PM
Investigating Generic Drug Safety doesn’t sound sexy, but it can save your life!
Listen to:
Joe Graedon of The People's Pharmacy
Katherine Eban, author, Bottle of Lies
David Y. Light founder, Valisure
Watch now for free! Investigating Generic Drug Safety medshadow.org/webinar/inve...
Listen to:
Joe Graedon of The People's Pharmacy
Katherine Eban, author, Bottle of Lies
David Y. Light founder, Valisure
Watch now for free! Investigating Generic Drug Safety medshadow.org/webinar/inve...
Reposted by Suzanne Robotti
Looking forward to participating in this Webinar on June 25. Hope you can join!
Discover how contamination, inconsistent dosages, and weak FDA oversight compromise generic drug safety.
🗒️ Join us on June 25 at 4:00 pm ET.
Register today at the link below 👇
shorturl.at/ZjUh7
🗒️ Join us on June 25 at 4:00 pm ET.
Register today at the link below 👇
shorturl.at/ZjUh7
June 17, 2025 at 12:59 PM
Looking forward to participating in this Webinar on June 25. Hope you can join!
Excellent article by Jeanne Lenzer and Shannon Brownlee on FDA drugs approved and found to be ineffective. A failure of FDA’s mission. I was one of 100+ plus experts, patients. I’m not named in this article-happy to give background.
www.levernews.com/fda-approved... FDA Approved — And Ineffective
www.levernews.com/fda-approved... FDA Approved — And Ineffective
FDA Approved — And Ineffective
Federal regulators have authorized hundreds of drugs without evidence they work, and many are dangerous.
www.levernews.com
June 5, 2025 at 5:08 PM
Excellent article by Jeanne Lenzer and Shannon Brownlee on FDA drugs approved and found to be ineffective. A failure of FDA’s mission. I was one of 100+ plus experts, patients. I’m not named in this article-happy to give background.
www.levernews.com/fda-approved... FDA Approved — And Ineffective
www.levernews.com/fda-approved... FDA Approved — And Ineffective
I’m so proud of the work that @medshadow.bsky.social is doing.
At MedShadow, we’re ALL ABOUT not falling for the propaganda when it comes to your #health.
Our reporting is backed by science, evidence, and expert insight. Learn more at MedShadow.org
#FDA #Supplements #Nurses #SideEffects #OTC #Rx
Our reporting is backed by science, evidence, and expert insight. Learn more at MedShadow.org
#FDA #Supplements #Nurses #SideEffects #OTC #Rx
May 29, 2025 at 10:46 PM
I’m so proud of the work that @medshadow.bsky.social is doing.
The new guidelines on who is recommended for covid vax may be right, but there’s no way to know without going through a scientific process. Great article in @ylepidemiologist.bsky.social
1/ Yesterday, the FDA Commissioner, Marty Makary, and his new advisor, Vinay Prasad, unveiled a major shift in U.S. Covid-19 vaccine policy. Their bottom line: Going forward, #Covid-19vaccines will only be recommended for people over 65 or with at least one chronic condition. 🧵
May 21, 2025 at 11:24 PM
The new guidelines on who is recommended for covid vax may be right, but there’s no way to know without going through a scientific process. Great article in @ylepidemiologist.bsky.social
Reposted by Suzanne Robotti
1/ Yesterday, the FDA Commissioner, Marty Makary, and his new advisor, Vinay Prasad, unveiled a major shift in U.S. Covid-19 vaccine policy. Their bottom line: Going forward, #Covid-19vaccines will only be recommended for people over 65 or with at least one chronic condition. 🧵
May 21, 2025 at 2:10 PM
1/ Yesterday, the FDA Commissioner, Marty Makary, and his new advisor, Vinay Prasad, unveiled a major shift in U.S. Covid-19 vaccine policy. Their bottom line: Going forward, #Covid-19vaccines will only be recommended for people over 65 or with at least one chronic condition. 🧵
As the founder of @medshadow.bsky.social I often get asked how to start a nonprofit. Surround yourself with people who can fill in your own knowledge gaps. Here are my six steps for starting a nonprofit. Did I miss any? What advice do you have?
www.bizjournals.com/pacific/bizw...
www.bizjournals.com/pacific/bizw...
www.bizjournals.com
May 12, 2025 at 2:34 PM
As the founder of @medshadow.bsky.social I often get asked how to start a nonprofit. Surround yourself with people who can fill in your own knowledge gaps. Here are my six steps for starting a nonprofit. Did I miss any? What advice do you have?
www.bizjournals.com/pacific/bizw...
www.bizjournals.com/pacific/bizw...
Congrats to @paceuniversity.bsky.social “Changemakers in Healthcare” award winners at the College of Health Professions (where I serve on the Advisory Bd):
1. Donald Moore, CEO/Owner, Dr. Donald Moore and Assoc 2. Beth Oliver, Chief Nurse Exec FP, Mount Sinai 3. McLee Smith, Area Pres, Gallagher
1. Donald Moore, CEO/Owner, Dr. Donald Moore and Assoc 2. Beth Oliver, Chief Nurse Exec FP, Mount Sinai 3. McLee Smith, Area Pres, Gallagher
May 12, 2025 at 1:31 PM
Congrats to @paceuniversity.bsky.social “Changemakers in Healthcare” award winners at the College of Health Professions (where I serve on the Advisory Bd):
1. Donald Moore, CEO/Owner, Dr. Donald Moore and Assoc 2. Beth Oliver, Chief Nurse Exec FP, Mount Sinai 3. McLee Smith, Area Pres, Gallagher
1. Donald Moore, CEO/Owner, Dr. Donald Moore and Assoc 2. Beth Oliver, Chief Nurse Exec FP, Mount Sinai 3. McLee Smith, Area Pres, Gallagher
Before anyone changes Advisory Committees, know that Consumer reps have a vote-Industry reps do not.
Cons reps advocate for patients & families. Industry reps advocate for pharma industry.
I was Cons rep on FDA DSARM 2017 to 2024
Read: John Wilkerson for @STAT: www.statnews.com/2025/04/17/f...
Cons reps advocate for patients & families. Industry reps advocate for pharma industry.
I was Cons rep on FDA DSARM 2017 to 2024
Read: John Wilkerson for @STAT: www.statnews.com/2025/04/17/f...
Makary says FDA will remove pharma representatives from advisory panels
Representatives from pharma and other industries already play a more limited role in advising the FDA.
www.statnews.com
May 5, 2025 at 2:34 PM
Before anyone changes Advisory Committees, know that Consumer reps have a vote-Industry reps do not.
Cons reps advocate for patients & families. Industry reps advocate for pharma industry.
I was Cons rep on FDA DSARM 2017 to 2024
Read: John Wilkerson for @STAT: www.statnews.com/2025/04/17/f...
Cons reps advocate for patients & families. Industry reps advocate for pharma industry.
I was Cons rep on FDA DSARM 2017 to 2024
Read: John Wilkerson for @STAT: www.statnews.com/2025/04/17/f...
This article is based on the important information that the FDA has stopped releasing. Our writer @health-journo-emma.bsky.social was told by FDA that the restructuring was delaying updates. No date for new updates
FDA Side Effects Updates are designed to keep you informed about the latest safety advisories and newly documented side effects of medications. Today, we highlight safety updates for Dotarem, Elucirem, Eovist, Gadavist, Multihance, Prohance, and Omniscan.
medshadow.org/fda-side-eff...
medshadow.org/fda-side-eff...
FDA SIDE EFFECTS UPDATE: Gadolinium Contrast Agents (GBCAs) and Lung Problems - MedShadow Foundation | Independent Health & Wellness Journalism
Stay informed with the latest FDA safety updates on GBCAs including Dotarem, Elucirem, Eovist, Gadavist, Multihance, Prohance, and Omniscan
medshadow.org
April 24, 2025 at 9:01 PM
This article is based on the important information that the FDA has stopped releasing. Our writer @health-journo-emma.bsky.social was told by FDA that the restructuring was delaying updates. No date for new updates
Reposted by Suzanne Robotti
FDA confirms several database updates—including serious drug safety updates—are delayed due to restructuring. My latest for @medshadow.bsky.social #medicine #fda #drugsafety medshadow.org/mission-crit...
Mission Critical Update: Medication Safety Updates from the FDA Delayed
FDA drug safety updates have stalled amid new administration decisions, raising concerns about delayed warnings and public transparency
medshadow.org
April 24, 2025 at 8:26 PM
FDA confirms several database updates—including serious drug safety updates—are delayed due to restructuring. My latest for @medshadow.bsky.social #medicine #fda #drugsafety medshadow.org/mission-crit...
… and now, the NIH cancels its largest study centered on women. Without studies like this, any care women receive will likely be based on results of studies on men.
www.whi.org/md/news/whi-...
www.whi.org/md/news/whi-...
4/20/2025
www.whi.org
April 24, 2025 at 5:51 PM
… and now, the NIH cancels its largest study centered on women. Without studies like this, any care women receive will likely be based on results of studies on men.
www.whi.org/md/news/whi-...
www.whi.org/md/news/whi-...
Hormone therapy (HT) during or after menopause has been controversial for decades. Despite @fda.gov head Marty Makary’s favorable take on HT in Blind Spot, @tarahaelle.bsky.social found a lot to be concerned about. Read her deeply researched article for @medshadow.bsky.social
Why Is Hormone Therapy Still So Misunderstood? - MedShadow Foundation | Independent Health & Wellness Journalism
Outdated data, dose differences, and personal factors complicate our understanding of hormone therapy risks.
medshadow.org
April 14, 2025 at 9:06 PM
Hormone therapy (HT) during or after menopause has been controversial for decades. Despite @fda.gov head Marty Makary’s favorable take on HT in Blind Spot, @tarahaelle.bsky.social found a lot to be concerned about. Read her deeply researched article for @medshadow.bsky.social
Because Marty Makary is the new head of the @fda.gov , I read his latest book, Blind Spots. I was hoping to get some insight into what kind of leader he would be and what his priorities would be.
Read my latest article for @medshadow.bsky.social
medshadow.org/makarys-blin...
Read my latest article for @medshadow.bsky.social
medshadow.org/makarys-blin...
Makary’s "Blind Spots" Offers Big Ideas — But Can He Deliver as FDA Commissioner? - MedShadow Foundation | Independent Health & Wellness Journalism
In his book Marty Makary makes a convincing case for challenging medical dogma. But can turn that vision into a reality at the FDA?
medshadow.org
April 11, 2025 at 3:30 PM
Because Marty Makary is the new head of the @fda.gov , I read his latest book, Blind Spots. I was hoping to get some insight into what kind of leader he would be and what his priorities would be.
Read my latest article for @medshadow.bsky.social
medshadow.org/makarys-blin...
Read my latest article for @medshadow.bsky.social
medshadow.org/makarys-blin...
Great new column - safety info on mixing two common needs
Welcome to the FDA Side Effects Update, designed to keep you informed about the latest safety advisories and newly documented side effects of your medications. In this installment, we highlight safety updates concerning Abilify, Adcertis, Enhertu, Dayvigo, and Osphena.
medshadow.org/fda-side-eff...
medshadow.org/fda-side-eff...
FDA SIDE EFFECTS UPDATE: Abilify Pregnancy Risk And More - MedShadow Foundation | Independent Health & Wellness Journalism
Stay informed on the latest medication safety advisories. This edition covers updates on Abilify, Adcertis, Enhertu, Dayvigo, and Osphena
medshadow.org
April 9, 2025 at 12:09 AM
Great new column - safety info on mixing two common needs
Thank you @oregonzoo.bsky.social
I need a reason to look up :)
I need a reason to look up :)
April 8, 2025 at 11:53 PM
Thank you @oregonzoo.bsky.social
I need a reason to look up :)
I need a reason to look up :)
Aging is messy. For seniors the signs of aging can feel humiliating as the body and mind we’ve depended on become less reliable. Help your seniors as they adjust to their new normal.
Compassion goes a long way.
Great article by @health-journo-emma.bsky.social medshadow.org/aging-whats-...
Compassion goes a long way.
Great article by @health-journo-emma.bsky.social medshadow.org/aging-whats-...
Aging - What's Normal? - MedShadow Foundation | Independent Health & Wellness Journalism
Older patients and healthcare providers can mistake treatable ailments as aging when they're signs of illness or overmedication. Read more.
medshadow.org
April 7, 2025 at 2:51 PM
Aging is messy. For seniors the signs of aging can feel humiliating as the body and mind we’ve depended on become less reliable. Help your seniors as they adjust to their new normal.
Compassion goes a long way.
Great article by @health-journo-emma.bsky.social medshadow.org/aging-whats-...
Compassion goes a long way.
Great article by @health-journo-emma.bsky.social medshadow.org/aging-whats-...
Drug cascades are getting more attention and for good reason. Doctors may treat new issues as symptoms rather than a side effect. Whenever a new symptom appears, assume that it’s a side effect of a medication. Discuss alternate drug options with your doctor.
March 31, 2025 at 2:54 PM
Drug cascades are getting more attention and for good reason. Doctors may treat new issues as symptoms rather than a side effect. Whenever a new symptom appears, assume that it’s a side effect of a medication. Discuss alternate drug options with your doctor.